Pulmonary Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product (Inhalers, Nebulizers, Accessories), By Application (Asthma, Cystic Fibrosis), By End-use, By Region And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Public Relations Tools Market Growth & Trends
The global public relations tools market size is estimated to reach USD 13.33 billion by 2030, registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. The recent years have seen a considerable change in the public relations (PR) landscape as it has taken the center stage in the marketing activities of organizations. There has been an increasing number of efforts at quantifying the impact of public relations and the return on investments in the related activities. The emergence of digital communication and social media is also contributing to the increased demand for tracking and monitoring the activities of organizations and customers on these media platforms, thus culminating into a widespread demand for the tools and techniques to keep a tab on the PR activities.
The public relations are forsaking their traditional boundaries to attract and engage customers for creating a larger following and building up long-term relationships, which are driving the growing trend of using a diverse set of tools in the industry. These techniques include the use of big data, analytics, machine learning, and artificial intelligence for the same purpose. The advent of digital media has also brought in new stakeholders in the PR industry, such as bloggers, influencers, and third-party platform providers, who need to be wooed to ensure the smooth creation and distribution of organization news.
The PR tools market is witnessing a steady rise in the demand for tools based on analytics and aggregation to better understand the current trends and predict the behavior of the public. Driven by the requirements from diverse industries ranging from retail and consumer goods to the information technology and healthcare industries, the market for PR tools is anticipated to see a considerable growth. The PR tools provide a wide range of capabilities from content creation and aggregation to the distribution of organization stories and automated report generation. In addition, the need for integrated marketing communications and the ability to reach a niche market segment are also helping the PR tools industry grow.
Public Relations Tools Market Report Highlights
Public Relations Tools Market Growth & Trends
The global public relations tools market size is estimated to reach USD 13.33 billion by 2030, registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. The recent years have seen a considerable change in the public relations (PR) landscape as it has taken the center stage in the marketing activities of organizations. There has been an increasing number of efforts at quantifying the impact of public relations and the return on investments in the related activities. The emergence of digital communication and social media is also contributing to the increased demand for tracking and monitoring the activities of organizations and customers on these media platforms, thus culminating into a widespread demand for the tools and techniques to keep a tab on the PR activities.
The public relations are forsaking their traditional boundaries to attract and engage customers for creating a larger following and building up long-term relationships, which are driving the growing trend of using a diverse set of tools in the industry. These techniques include the use of big data, analytics, machine learning, and artificial intelligence for the same purpose. The advent of digital media has also brought in new stakeholders in the PR industry, such as bloggers, influencers, and third-party platform providers, who need to be wooed to ensure the smooth creation and distribution of organization news.
The PR tools market is witnessing a steady rise in the demand for tools based on analytics and aggregation to better understand the current trends and predict the behavior of the public. Driven by the requirements from diverse industries ranging from retail and consumer goods to the information technology and healthcare industries, the market for PR tools is anticipated to see a considerable growth. The PR tools provide a wide range of capabilities from content creation and aggregation to the distribution of organization stories and automated report generation. In addition, the need for integrated marketing communications and the ability to reach a niche market segment are also helping the PR tools industry grow.
Public Relations Tools Market Report Highlights
- The public relations scenario is being dominated by the ephemeral content, which includes a growing number of videos, images, and infographics
- The public relations tools market is marked by the presence of a large number of solution providers, which offer differentiated products that deliver a wide range of varied tasks and capabilities
- The online media segment dominated the market in 2023. Companies recognize the importance of online media PR strategies for improving online visibility and brand awareness.
- The new product development, industry players’ concentration on research and development activities, and developing cost effective products for a differential market are the major strategic plans adopted by the industry players
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PULMONARY DRUG DELIVERY SYSTEMS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Pulmonary Drug Delivery Systems Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. PULMONARY DRUG DELIVERY SYSTEMS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Pulmonary Drug Delivery Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Inhalers
4.3.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Nebulizers
4.4.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Accessories
4.5.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PULMONARY DRUG DELIVERY SYSTEMS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Pulmonary Drug Delivery Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Asthma
5.3.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Cystic Fibrosis
5.4.1. Cystic Fibrosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Chronic Obstructive Pulmonary Disease (COPD)
5.5.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Allergic Rhinitis
5.6.1. Allergic Rhinitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Pulmonary Arterial Hypertension
5.7.1. Pulmonary Arterial Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PULMONARY DRUG DELIVERY SYSTEMS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Pulmonary Drug Delivery Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Ambulatory Surgical Centers (ASCs)
6.4.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Home Care
6.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. PULMONARY DRUG DELIVERY SYSTEMS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Pulmonary Drug Delivery Systems Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. 3M
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. AstraZeneca
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. GSK plc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Novartis AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Koninklijke Philips N.V.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Boehringer Ingelheim International GmbH.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Teva Pharmaceutical Industries Ltd.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. OMRON Healthcare, Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. PARI GmbH
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Cipla
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PULMONARY DRUG DELIVERY SYSTEMS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Pulmonary Drug Delivery Systems Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. PULMONARY DRUG DELIVERY SYSTEMS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Pulmonary Drug Delivery Systems Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Inhalers
4.3.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Nebulizers
4.4.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Accessories
4.5.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PULMONARY DRUG DELIVERY SYSTEMS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Pulmonary Drug Delivery Systems Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Asthma
5.3.1. Asthma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Cystic Fibrosis
5.4.1. Cystic Fibrosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Chronic Obstructive Pulmonary Disease (COPD)
5.5.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Allergic Rhinitis
5.6.1. Allergic Rhinitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Pulmonary Arterial Hypertension
5.7.1. Pulmonary Arterial Hypertension Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PULMONARY DRUG DELIVERY SYSTEMS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Pulmonary Drug Delivery Systems Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals & Clinics
6.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Ambulatory Surgical Centers (ASCs)
6.4.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Home Care
6.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. PULMONARY DRUG DELIVERY SYSTEMS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Pulmonary Drug Delivery Systems Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Pulmonary Drug Delivery Systems Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. 3M
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. AstraZeneca
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. GSK plc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Novartis AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Koninklijke Philips N.V.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Boehringer Ingelheim International GmbH.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Teva Pharmaceutical Industries Ltd.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. OMRON Healthcare, Inc.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. PARI GmbH
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Cipla
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
